vasoactive-intestinal-peptide has been researched along with Sensation-Disorders* in 2 studies
2 other study(ies) available for vasoactive-intestinal-peptide and Sensation-Disorders
Article | Year |
---|---|
Neuropeptide expression in the ferret trigeminal ganglion following ligation of the inferior alveolar nerve.
Previous studies have found changes in neuropeptide expression in trigeminal ganglion cells after inferior alveolar nerve (IAN) section. These changes may play a part in the persistent sensory abnormalities that can be experienced after trigeminal nerve injuries. Here, neuropeptide expression after IAN ligation was studied, as this type of injury is thought to be more likely to result in sensory disturbances. The neuropeptides investigated were substance P, calcitonin gene-related peptide, enkephalin (ENK), galanin (GAL), neuropeptide Y (NPY) and vasoactive intestinal polypeptide. In anaesthetised adult female ferrets the left IAN was sectioned and the central stump tightly ligated. Recovery was allowed for 3 days, 3 or 12 weeks before perfusion-fixation. In a second procedure, 1 week before perfusion, the IAN was exposed and an injection made central to the injury site, using a mixture of 4% Fluorogold and 4% Isolectin B4 conjugated to horseradish peroxidase, to identify cell bodies with axons in the inferior alveolar nerve and cells with unmyelinated axons within this population, respectively. Control experiments involved tracer injection alone. After harvesting the tissue, sagittal sections were taken from both the right and left ganglia and immunohistochemical staining used to reveal the presence of peptides and Isolectin B4 tracer. The results showed a significant decrease in GAL expression after injury and an increase in ENK and NPY expression. No significant differences were seen in the expression of the other peptides or in the proportion of lectin-positive cells at any time after injury. When compared with previous data, significant differences were found between peptide expression following nerve ligation and nerve section. These results reveal that the changes in neuropeptide expression in the trigeminal ganglion that follow IAN injury are dependent upon the type of injury. The extent to which changes in the central neuropeptide levels contribute to the development of sensory disorders remains to be established. Topics: Analysis of Variance; Animals; Axons; Calcitonin Gene-Related Peptide; Cell Count; Disease Models, Animal; Enkephalins; Female; Ferrets; Fluorescent Dyes; Follow-Up Studies; Galanin; Gene Expression; Horseradish Peroxidase; Immunohistochemistry; Lectins; Ligation; Mandibular Nerve; Neural Pathways; Neuropeptide Y; Neuropeptides; Sensation Disorders; Statistics as Topic; Stilbamidines; Substance P; Trigeminal Ganglion; Trigeminal Nerve Injuries; Vasoactive Intestinal Peptide | 2001 |
Possible involvement of neuropeptidergic sensory nerves in alopecia areata.
Alopecia areata (AA) is a dermatosis involving the sudden occurrence of bald patches on the scalp. Although the aetiology is unknown, experimental data indicate that cutaneous microcirculation plays an important role. The skin is richly innervated by neuropeptidergic sensory nerves that help regulate microvascular circulation. This study shows a reduction of cutaneous levels of substance P and calcitonin gene-related peptide (CGRP) but not of vasoactive intestinal polypeptide in scalp biopsies from patients with AA. Laser-Doppler flowmetry was used to study microcirculation of the scalp. Results indicate that patients with AA have lower basal blood flow and greater vasodilatation following intradermal CGRP injection than control subjects. A vascular hyper-reactivity to vasodilatatory substances such as neuropeptides, probably because of the lack of these substances, is hypothesized. Topics: Adolescent; Adult; Alopecia Areata; Biopsy; Calcitonin Gene-Related Peptide; Case-Control Studies; Humans; Injections, Subcutaneous; Laser-Doppler Flowmetry; Microcirculation; Middle Aged; Neurons, Afferent; Neuropeptides; Radioimmunoassay; Scalp; Sensation Disorders; Substance P; Vasoactive Intestinal Peptide | 1997 |